In ovarian cancer, CLIC1 has been identified as a promising biomarker (Ye et al., 2015; Singha et al., 2018) with prognostic value (Yu et al., 2018), impacting patient survival and possibly serving in conjunction with CLIC4. The gene discussed is CLIC1; the disease is ovarian cancer.